- Naoum, Christopher
- Berman, Daniel S
- Ahmadi, Amir
- Blanke, Philipp
- Gransar, Heidi
- Narula, Jagat
- Shaw, Leslee J
- Kritharides, Leonard
- Achenbach, Stephan
- Al-Mallah, Mouaz H
- Andreini, Daniele
- Budoff, Matthew J
- Cademartiri, Filippo
- Callister, Tracy Q
- Chang, Hyuk-Jae
- Chinnaiyan, Kavitha
- Chow, Benjamin
- Cury, Ricardo C
- DeLago, Augustin
- Dunning, Allison
- Feuchtner, Gudrun
- Hadamitzky, Martin
- Hausleiter, Joerg
- Kaufmann, Philipp A
- Kim, Yong-Jin
- Maffei, Erica
- Marquez, Hugo
- Pontone, Gianluca
- Raff, Gilbert
- Rubinshtein, Ronen
- Villines, Todd C
- Min, James
- Leipsic, Jonathon
- et al.
Background
Age-adjusted coronary artery disease (CAD) burden identified on coronary computed tomography angiography predicts major adverse cardiovascular event (MACE) risk; however, it seldom contributes to clinical decision making because of a lack of nomographic data. We aimed to develop clinically pragmatic age- and sex-specific nomograms of CAD burden using coronary computed tomography angiography and to validate their prognostic use.Methods and results
Patients prospectively enrolled in phase I of the CONFIRM registry (Coronary CT Angiography Evaluation for Clinical Outcomes) were included (derivation cohort: n=21,132; 46% female) to develop CAD nomograms based on age-sex percentiles of segment involvement score (SIS) at each year of life (40-79 years). The relationship between SIS age-sex percentiles (SIS%) and MACE (all-cause death, myocardial infarction, unstable angina, and late revascularization) was tested in a nonoverlapping validation cohort (phase II, CONFIRM registry; n=3030, 44% female) by stratifying patients into 3 SIS% groups (≤50th, 51-75th, and >75th) and comparing annualized MACE rates and time to MACE using multivariable Cox proportional hazards models adjusting for Framingham risk and chest pain typicality. Age-sex percentiles were well fitted to second-order polynomial curves (men: R2=0.86±0.12; women: R2=0.86±0.14). Using the nomograms, there were 1576, 965, and 489 patients, respectively, in the ≤50th, 51-75th, and >75th SIS% groups. Annualized event rates were higher among patients with greater CAD burden (2.1% [95% confidence interval: 1.7%-2.7%], 3.9% [95% confidence interval: 3.0%-5.1%], and 7.2% [95% confidence interval: 5.4%-9.6%] in ≤50th, 51-75th, and >75th SIS% groups, respectively; P<0.001). Adjusted MACE risk was significantly increased among patients in SIS% groups above the median compared with patients below the median (hazard ratio [95% confidence interval]: 1.9 [1.3-2.8] for 51-75th SIS% group and 3.4 [2.3-5.0] for >75th SIS% group; P<0.01 for both).Conclusions
We have developed clinically pragmatic age- and sex-specific nomograms of CAD prevalence using coronary computed tomography angiography findings. Global plaque burden measured using SIS% is predictive of cardiac events independent of traditional risk assessment.Clinical trial registration
URL: https://www.clinicaltrials.gov. Unique identifier: NCT01443637.